Global Sargramostim Market Growth 2026-2032
The global Sargramostim market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Sargramostim is a recombinant form of human granulocyte-macrophage colony-stimulating factor (GM-CSF) that stimulates the production and activation of neutrophils and macrophages from bone marrow progenitor cells. It is primarily used to treat neutropenia in patients undergoing chemotherapy, radiation therapy, or bone marrow transplantation, helping to reduce the risk of infections by enhancing the body’s immune response. Sargramostim is available in multiple forms, including a lyophilized powder for injection, which can be reconstituted for subcutaneous or intravenous administration, and an inhalation formulation.
United States market for Sargramostim is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Sargramostim is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Sargramostim is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Sargramostim players cover Partner Therapeutics, Nobelpharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Sargramostim Industry Forecast” looks at past sales and reviews total world Sargramostim sales in 2025, providing a comprehensive analysis by region and market sector of projected Sargramostim sales for 2026 through 2032. With Sargramostim sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sargramostim industry.
This Insight Report provides a comprehensive analysis of the global Sargramostim landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sargramostim portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sargramostim market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sargramostim and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sargramostim.
This report presents a comprehensive overview, market shares, and growth opportunities of Sargramostim market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Sargramostim market?
What factors are driving Sargramostim market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sargramostim market opportunities vary by end market size?
How does Sargramostim break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Sargramostim is a recombinant form of human granulocyte-macrophage colony-stimulating factor (GM-CSF) that stimulates the production and activation of neutrophils and macrophages from bone marrow progenitor cells. It is primarily used to treat neutropenia in patients undergoing chemotherapy, radiation therapy, or bone marrow transplantation, helping to reduce the risk of infections by enhancing the body’s immune response. Sargramostim is available in multiple forms, including a lyophilized powder for injection, which can be reconstituted for subcutaneous or intravenous administration, and an inhalation formulation.
United States market for Sargramostim is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Sargramostim is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Sargramostim is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Sargramostim players cover Partner Therapeutics, Nobelpharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Sargramostim Industry Forecast” looks at past sales and reviews total world Sargramostim sales in 2025, providing a comprehensive analysis by region and market sector of projected Sargramostim sales for 2026 through 2032. With Sargramostim sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sargramostim industry.
This Insight Report provides a comprehensive analysis of the global Sargramostim landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sargramostim portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sargramostim market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sargramostim and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sargramostim.
This report presents a comprehensive overview, market shares, and growth opportunities of Sargramostim market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Inhalation
- Acute Radiation Syndrome
- Proteinosis Autoimmune Pulmonary Alveolar
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Partner Therapeutics
- Nobelpharma
What is the 10-year outlook for the global Sargramostim market?
What factors are driving Sargramostim market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sargramostim market opportunities vary by end market size?
How does Sargramostim break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sargramostim Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Sargramostim by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Sargramostim by Country/Region, 2021, 2025 & 2032
2.2 Sargramostim Segment by Type
2.2.1 Injection
2.2.2 Inhalation
2.2.3 Sargramostim Sales by Type
2.2.3.1 Global Sargramostim Sales Market Share by Type (2021-2026)
2.2.3.2 Global Sargramostim Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Sargramostim Sale Price by Type (2021-2026)
2.3 Sargramostim Segment by Application
2.3.1 Acute Radiation Syndrome
2.3.2 Proteinosis Autoimmune Pulmonary Alveolar
2.3.3 Cancer
2.3.4 Other
2.3.5 Sargramostim Sales by Application
2.3.5.1 Global Sargramostim Sale Market Share by Application (2021-2026)
2.3.5.2 Global Sargramostim Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Sargramostim Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Sargramostim Breakdown Data by Company
3.1.1 Global Sargramostim Annual Sales by Company (2021-2026)
3.1.2 Global Sargramostim Sales Market Share by Company (2021-2026)
3.2 Global Sargramostim Annual Revenue by Company (2021-2026)
3.2.1 Global Sargramostim Revenue by Company (2021-2026)
3.2.2 Global Sargramostim Revenue Market Share by Company (2021-2026)
3.3 Global Sargramostim Sale Price by Company
3.4 Key Manufacturers Sargramostim Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sargramostim Product Location Distribution
3.4.2 Players Sargramostim Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SARGRAMOSTIM BY GEOGRAPHIC REGION
4.1 World Historic Sargramostim Market Size by Geographic Region (2021-2026)
4.1.1 Global Sargramostim Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Sargramostim Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sargramostim Market Size by Country/Region (2021-2026)
4.2.1 Global Sargramostim Annual Sales by Country/Region (2021-2026)
4.2.2 Global Sargramostim Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sargramostim Sales Growth
4.4 APAC Sargramostim Sales Growth
4.5 Europe Sargramostim Sales Growth
4.6 Middle East & Africa Sargramostim Sales Growth
5 AMERICAS
5.1 Americas Sargramostim Sales by Country
5.1.1 Americas Sargramostim Sales by Country (2021-2026)
5.1.2 Americas Sargramostim Revenue by Country (2021-2026)
5.2 Americas Sargramostim Sales by Type (2021-2026)
5.3 Americas Sargramostim Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sargramostim Sales by Region
6.1.1 APAC Sargramostim Sales by Region (2021-2026)
6.1.2 APAC Sargramostim Revenue by Region (2021-2026)
6.2 APAC Sargramostim Sales by Type (2021-2026)
6.3 APAC Sargramostim Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sargramostim by Country
7.1.1 Europe Sargramostim Sales by Country (2021-2026)
7.1.2 Europe Sargramostim Revenue by Country (2021-2026)
7.2 Europe Sargramostim Sales by Type (2021-2026)
7.3 Europe Sargramostim Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sargramostim by Country
8.1.1 Middle East & Africa Sargramostim Sales by Country (2021-2026)
8.1.2 Middle East & Africa Sargramostim Revenue by Country (2021-2026)
8.2 Middle East & Africa Sargramostim Sales by Type (2021-2026)
8.3 Middle East & Africa Sargramostim Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sargramostim
10.3 Manufacturing Process Analysis of Sargramostim
10.4 Industry Chain Structure of Sargramostim
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sargramostim Distributors
11.3 Sargramostim Customer
12 WORLD FORECAST REVIEW FOR SARGRAMOSTIM BY GEOGRAPHIC REGION
12.1 Global Sargramostim Market Size Forecast by Region
12.1.1 Global Sargramostim Forecast by Region (2027-2032)
12.1.2 Global Sargramostim Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sargramostim Forecast by Type (2027-2032)
12.7 Global Sargramostim Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Partner Therapeutics
13.1.1 Partner Therapeutics Company Information
13.1.2 Partner Therapeutics Sargramostim Product Portfolios and Specifications
13.1.3 Partner Therapeutics Sargramostim Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Partner Therapeutics Main Business Overview
13.1.5 Partner Therapeutics Latest Developments
13.2 Nobelpharma
13.2.1 Nobelpharma Company Information
13.2.2 Nobelpharma Sargramostim Product Portfolios and Specifications
13.2.3 Nobelpharma Sargramostim Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Nobelpharma Main Business Overview
13.2.5 Nobelpharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sargramostim Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Sargramostim by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Sargramostim by Country/Region, 2021, 2025 & 2032
2.2 Sargramostim Segment by Type
2.2.1 Injection
2.2.2 Inhalation
2.2.3 Sargramostim Sales by Type
2.2.3.1 Global Sargramostim Sales Market Share by Type (2021-2026)
2.2.3.2 Global Sargramostim Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Sargramostim Sale Price by Type (2021-2026)
2.3 Sargramostim Segment by Application
2.3.1 Acute Radiation Syndrome
2.3.2 Proteinosis Autoimmune Pulmonary Alveolar
2.3.3 Cancer
2.3.4 Other
2.3.5 Sargramostim Sales by Application
2.3.5.1 Global Sargramostim Sale Market Share by Application (2021-2026)
2.3.5.2 Global Sargramostim Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Sargramostim Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Sargramostim Breakdown Data by Company
3.1.1 Global Sargramostim Annual Sales by Company (2021-2026)
3.1.2 Global Sargramostim Sales Market Share by Company (2021-2026)
3.2 Global Sargramostim Annual Revenue by Company (2021-2026)
3.2.1 Global Sargramostim Revenue by Company (2021-2026)
3.2.2 Global Sargramostim Revenue Market Share by Company (2021-2026)
3.3 Global Sargramostim Sale Price by Company
3.4 Key Manufacturers Sargramostim Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sargramostim Product Location Distribution
3.4.2 Players Sargramostim Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SARGRAMOSTIM BY GEOGRAPHIC REGION
4.1 World Historic Sargramostim Market Size by Geographic Region (2021-2026)
4.1.1 Global Sargramostim Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Sargramostim Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sargramostim Market Size by Country/Region (2021-2026)
4.2.1 Global Sargramostim Annual Sales by Country/Region (2021-2026)
4.2.2 Global Sargramostim Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sargramostim Sales Growth
4.4 APAC Sargramostim Sales Growth
4.5 Europe Sargramostim Sales Growth
4.6 Middle East & Africa Sargramostim Sales Growth
5 AMERICAS
5.1 Americas Sargramostim Sales by Country
5.1.1 Americas Sargramostim Sales by Country (2021-2026)
5.1.2 Americas Sargramostim Revenue by Country (2021-2026)
5.2 Americas Sargramostim Sales by Type (2021-2026)
5.3 Americas Sargramostim Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sargramostim Sales by Region
6.1.1 APAC Sargramostim Sales by Region (2021-2026)
6.1.2 APAC Sargramostim Revenue by Region (2021-2026)
6.2 APAC Sargramostim Sales by Type (2021-2026)
6.3 APAC Sargramostim Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sargramostim by Country
7.1.1 Europe Sargramostim Sales by Country (2021-2026)
7.1.2 Europe Sargramostim Revenue by Country (2021-2026)
7.2 Europe Sargramostim Sales by Type (2021-2026)
7.3 Europe Sargramostim Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sargramostim by Country
8.1.1 Middle East & Africa Sargramostim Sales by Country (2021-2026)
8.1.2 Middle East & Africa Sargramostim Revenue by Country (2021-2026)
8.2 Middle East & Africa Sargramostim Sales by Type (2021-2026)
8.3 Middle East & Africa Sargramostim Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sargramostim
10.3 Manufacturing Process Analysis of Sargramostim
10.4 Industry Chain Structure of Sargramostim
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sargramostim Distributors
11.3 Sargramostim Customer
12 WORLD FORECAST REVIEW FOR SARGRAMOSTIM BY GEOGRAPHIC REGION
12.1 Global Sargramostim Market Size Forecast by Region
12.1.1 Global Sargramostim Forecast by Region (2027-2032)
12.1.2 Global Sargramostim Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sargramostim Forecast by Type (2027-2032)
12.7 Global Sargramostim Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Partner Therapeutics
13.1.1 Partner Therapeutics Company Information
13.1.2 Partner Therapeutics Sargramostim Product Portfolios and Specifications
13.1.3 Partner Therapeutics Sargramostim Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Partner Therapeutics Main Business Overview
13.1.5 Partner Therapeutics Latest Developments
13.2 Nobelpharma
13.2.1 Nobelpharma Company Information
13.2.2 Nobelpharma Sargramostim Product Portfolios and Specifications
13.2.3 Nobelpharma Sargramostim Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Nobelpharma Main Business Overview
13.2.5 Nobelpharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sargramostim Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sargramostim Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Inhalation
Table 5. Global Sargramostim Sales by Type (2021-2026) & (K Units)
Table 6. Global Sargramostim Sales Market Share by Type (2021-2026)
Table 7. Global Sargramostim Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sargramostim Revenue Market Share by Type (2021-2026)
Table 9. Global Sargramostim Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Sargramostim Sale by Application (2021-2026) & (K Units)
Table 11. Global Sargramostim Sale Market Share by Application (2021-2026)
Table 12. Global Sargramostim Revenue by Application (2021-2026) & ($ million)
Table 13. Global Sargramostim Revenue Market Share by Application (2021-2026)
Table 14. Global Sargramostim Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Sargramostim Sales by Company (2021-2026) & (K Units)
Table 16. Global Sargramostim Sales Market Share by Company (2021-2026)
Table 17. Global Sargramostim Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Sargramostim Revenue Market Share by Company (2021-2026)
Table 19. Global Sargramostim Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Sargramostim Producing Area Distribution and Sales Area
Table 21. Players Sargramostim Products Offered
Table 22. Sargramostim Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sargramostim Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Sargramostim Sales Market Share Geographic Region (2021-2026)
Table 27. Global Sargramostim Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Sargramostim Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Sargramostim Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Sargramostim Sales Market Share by Country/Region (2021-2026)
Table 31. Global Sargramostim Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Sargramostim Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Sargramostim Sales by Country (2021-2026) & (K Units)
Table 34. Americas Sargramostim Sales Market Share by Country (2021-2026)
Table 35. Americas Sargramostim Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Sargramostim Sales by Type (2021-2026) & (K Units)
Table 37. Americas Sargramostim Sales by Application (2021-2026) & (K Units)
Table 38. APAC Sargramostim Sales by Region (2021-2026) & (K Units)
Table 39. APAC Sargramostim Sales Market Share by Region (2021-2026)
Table 40. APAC Sargramostim Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Sargramostim Sales by Type (2021-2026) & (K Units)
Table 42. APAC Sargramostim Sales by Application (2021-2026) & (K Units)
Table 43. Europe Sargramostim Sales by Country (2021-2026) & (K Units)
Table 44. Europe Sargramostim Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Sargramostim Sales by Type (2021-2026) & (K Units)
Table 46. Europe Sargramostim Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Sargramostim Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Sargramostim Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Sargramostim Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Sargramostim Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sargramostim
Table 52. Key Market Challenges & Risks of Sargramostim
Table 53. Key Industry Trends of Sargramostim
Table 54. Sargramostim Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sargramostim Distributors List
Table 57. Sargramostim Customer List
Table 58. Global Sargramostim Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Sargramostim Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Sargramostim Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Sargramostim Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Sargramostim Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Sargramostim Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Sargramostim Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Sargramostim Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Sargramostim Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Sargramostim Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Sargramostim Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Sargramostim Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Sargramostim Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Sargramostim Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Partner Therapeutics Basic Information, Sargramostim Manufacturing Base, Sales Area and Its Competitors
Table 73. Partner Therapeutics Sargramostim Product Portfolios and Specifications
Table 74. Partner Therapeutics Sargramostim Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Partner Therapeutics Main Business
Table 76. Partner Therapeutics Latest Developments
Table 77. Nobelpharma Basic Information, Sargramostim Manufacturing Base, Sales Area and Its Competitors
Table 78. Nobelpharma Sargramostim Product Portfolios and Specifications
Table 79. Nobelpharma Sargramostim Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Nobelpharma Main Business
Table 81. Nobelpharma Latest Developments
Table 1. Sargramostim Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sargramostim Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Inhalation
Table 5. Global Sargramostim Sales by Type (2021-2026) & (K Units)
Table 6. Global Sargramostim Sales Market Share by Type (2021-2026)
Table 7. Global Sargramostim Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sargramostim Revenue Market Share by Type (2021-2026)
Table 9. Global Sargramostim Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Sargramostim Sale by Application (2021-2026) & (K Units)
Table 11. Global Sargramostim Sale Market Share by Application (2021-2026)
Table 12. Global Sargramostim Revenue by Application (2021-2026) & ($ million)
Table 13. Global Sargramostim Revenue Market Share by Application (2021-2026)
Table 14. Global Sargramostim Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Sargramostim Sales by Company (2021-2026) & (K Units)
Table 16. Global Sargramostim Sales Market Share by Company (2021-2026)
Table 17. Global Sargramostim Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Sargramostim Revenue Market Share by Company (2021-2026)
Table 19. Global Sargramostim Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Sargramostim Producing Area Distribution and Sales Area
Table 21. Players Sargramostim Products Offered
Table 22. Sargramostim Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sargramostim Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Sargramostim Sales Market Share Geographic Region (2021-2026)
Table 27. Global Sargramostim Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Sargramostim Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Sargramostim Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Sargramostim Sales Market Share by Country/Region (2021-2026)
Table 31. Global Sargramostim Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Sargramostim Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Sargramostim Sales by Country (2021-2026) & (K Units)
Table 34. Americas Sargramostim Sales Market Share by Country (2021-2026)
Table 35. Americas Sargramostim Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Sargramostim Sales by Type (2021-2026) & (K Units)
Table 37. Americas Sargramostim Sales by Application (2021-2026) & (K Units)
Table 38. APAC Sargramostim Sales by Region (2021-2026) & (K Units)
Table 39. APAC Sargramostim Sales Market Share by Region (2021-2026)
Table 40. APAC Sargramostim Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Sargramostim Sales by Type (2021-2026) & (K Units)
Table 42. APAC Sargramostim Sales by Application (2021-2026) & (K Units)
Table 43. Europe Sargramostim Sales by Country (2021-2026) & (K Units)
Table 44. Europe Sargramostim Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Sargramostim Sales by Type (2021-2026) & (K Units)
Table 46. Europe Sargramostim Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Sargramostim Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Sargramostim Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Sargramostim Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Sargramostim Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sargramostim
Table 52. Key Market Challenges & Risks of Sargramostim
Table 53. Key Industry Trends of Sargramostim
Table 54. Sargramostim Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sargramostim Distributors List
Table 57. Sargramostim Customer List
Table 58. Global Sargramostim Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Sargramostim Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Sargramostim Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Sargramostim Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Sargramostim Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Sargramostim Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Sargramostim Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Sargramostim Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Sargramostim Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Sargramostim Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Sargramostim Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Sargramostim Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Sargramostim Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Sargramostim Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Partner Therapeutics Basic Information, Sargramostim Manufacturing Base, Sales Area and Its Competitors
Table 73. Partner Therapeutics Sargramostim Product Portfolios and Specifications
Table 74. Partner Therapeutics Sargramostim Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Partner Therapeutics Main Business
Table 76. Partner Therapeutics Latest Developments
Table 77. Nobelpharma Basic Information, Sargramostim Manufacturing Base, Sales Area and Its Competitors
Table 78. Nobelpharma Sargramostim Product Portfolios and Specifications
Table 79. Nobelpharma Sargramostim Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Nobelpharma Main Business
Table 81. Nobelpharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sargramostim
Figure 2. Sargramostim Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sargramostim Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Sargramostim Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sargramostim Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sargramostim Sales Market Share by Country/Region (2025)
Figure 10. Sargramostim Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Inhalation
Figure 13. Global Sargramostim Sales Market Share by Type in 2026
Figure 14. Global Sargramostim Revenue Market Share by Type (2021-2026)
Figure 15. Sargramostim Consumed in Acute Radiation Syndrome
Figure 16. Global Sargramostim Market: Acute Radiation Syndrome (2021-2026) & (K Units)
Figure 17. Sargramostim Consumed in Proteinosis Autoimmune Pulmonary Alveolar
Figure 18. Global Sargramostim Market: Proteinosis Autoimmune Pulmonary Alveolar (2021-2026) & (K Units)
Figure 19. Sargramostim Consumed in Cancer
Figure 20. Global Sargramostim Market: Cancer (2021-2026) & (K Units)
Figure 21. Sargramostim Consumed in Other
Figure 22. Global Sargramostim Market: Other (2021-2026) & (K Units)
Figure 23. Global Sargramostim Sale Market Share by Application (2025)
Figure 24. Global Sargramostim Revenue Market Share by Application in 2026
Figure 25. Sargramostim Sales by Company in 2026 (K Units)
Figure 26. Global Sargramostim Sales Market Share by Company in 2026
Figure 27. Sargramostim Revenue by Company in 2026 ($ millions)
Figure 28. Global Sargramostim Revenue Market Share by Company in 2026
Figure 29. Global Sargramostim Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Sargramostim Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Sargramostim Sales 2021-2026 (K Units)
Figure 32. Americas Sargramostim Revenue 2021-2026 ($ millions)
Figure 33. APAC Sargramostim Sales 2021-2026 (K Units)
Figure 34. APAC Sargramostim Revenue 2021-2026 ($ millions)
Figure 35. Europe Sargramostim Sales 2021-2026 (K Units)
Figure 36. Europe Sargramostim Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Sargramostim Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Sargramostim Revenue 2021-2026 ($ millions)
Figure 39. Americas Sargramostim Sales Market Share by Country in 2026
Figure 40. Americas Sargramostim Revenue Market Share by Country (2021-2026)
Figure 41. Americas Sargramostim Sales Market Share by Type (2021-2026)
Figure 42. Americas Sargramostim Sales Market Share by Application (2021-2026)
Figure 43. United States Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Sargramostim Sales Market Share by Region in 2026
Figure 48. APAC Sargramostim Revenue Market Share by Region (2021-2026)
Figure 49. APAC Sargramostim Sales Market Share by Type (2021-2026)
Figure 50. APAC Sargramostim Sales Market Share by Application (2021-2026)
Figure 51. China Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 55. India Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Sargramostim Sales Market Share by Country in 2026
Figure 59. Europe Sargramostim Revenue Market Share by Country (2021-2026)
Figure 60. Europe Sargramostim Sales Market Share by Type (2021-2026)
Figure 61. Europe Sargramostim Sales Market Share by Application (2021-2026)
Figure 62. Germany Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 63. France Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Sargramostim Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Sargramostim Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Sargramostim Sales Market Share by Application (2021-2026)
Figure 70. Egypt Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Sargramostim in 2026
Figure 76. Manufacturing Process Analysis of Sargramostim
Figure 77. Industry Chain Structure of Sargramostim
Figure 78. Channels of Distribution
Figure 79. Global Sargramostim Sales Market Forecast by Region (2027-2032)
Figure 80. Global Sargramostim Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Sargramostim Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Sargramostim Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Sargramostim Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Sargramostim Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Sargramostim
Figure 2. Sargramostim Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sargramostim Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Sargramostim Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sargramostim Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sargramostim Sales Market Share by Country/Region (2025)
Figure 10. Sargramostim Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Inhalation
Figure 13. Global Sargramostim Sales Market Share by Type in 2026
Figure 14. Global Sargramostim Revenue Market Share by Type (2021-2026)
Figure 15. Sargramostim Consumed in Acute Radiation Syndrome
Figure 16. Global Sargramostim Market: Acute Radiation Syndrome (2021-2026) & (K Units)
Figure 17. Sargramostim Consumed in Proteinosis Autoimmune Pulmonary Alveolar
Figure 18. Global Sargramostim Market: Proteinosis Autoimmune Pulmonary Alveolar (2021-2026) & (K Units)
Figure 19. Sargramostim Consumed in Cancer
Figure 20. Global Sargramostim Market: Cancer (2021-2026) & (K Units)
Figure 21. Sargramostim Consumed in Other
Figure 22. Global Sargramostim Market: Other (2021-2026) & (K Units)
Figure 23. Global Sargramostim Sale Market Share by Application (2025)
Figure 24. Global Sargramostim Revenue Market Share by Application in 2026
Figure 25. Sargramostim Sales by Company in 2026 (K Units)
Figure 26. Global Sargramostim Sales Market Share by Company in 2026
Figure 27. Sargramostim Revenue by Company in 2026 ($ millions)
Figure 28. Global Sargramostim Revenue Market Share by Company in 2026
Figure 29. Global Sargramostim Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Sargramostim Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Sargramostim Sales 2021-2026 (K Units)
Figure 32. Americas Sargramostim Revenue 2021-2026 ($ millions)
Figure 33. APAC Sargramostim Sales 2021-2026 (K Units)
Figure 34. APAC Sargramostim Revenue 2021-2026 ($ millions)
Figure 35. Europe Sargramostim Sales 2021-2026 (K Units)
Figure 36. Europe Sargramostim Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Sargramostim Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Sargramostim Revenue 2021-2026 ($ millions)
Figure 39. Americas Sargramostim Sales Market Share by Country in 2026
Figure 40. Americas Sargramostim Revenue Market Share by Country (2021-2026)
Figure 41. Americas Sargramostim Sales Market Share by Type (2021-2026)
Figure 42. Americas Sargramostim Sales Market Share by Application (2021-2026)
Figure 43. United States Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Sargramostim Sales Market Share by Region in 2026
Figure 48. APAC Sargramostim Revenue Market Share by Region (2021-2026)
Figure 49. APAC Sargramostim Sales Market Share by Type (2021-2026)
Figure 50. APAC Sargramostim Sales Market Share by Application (2021-2026)
Figure 51. China Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 55. India Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Sargramostim Sales Market Share by Country in 2026
Figure 59. Europe Sargramostim Revenue Market Share by Country (2021-2026)
Figure 60. Europe Sargramostim Sales Market Share by Type (2021-2026)
Figure 61. Europe Sargramostim Sales Market Share by Application (2021-2026)
Figure 62. Germany Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 63. France Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Sargramostim Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Sargramostim Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Sargramostim Sales Market Share by Application (2021-2026)
Figure 70. Egypt Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Sargramostim Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Sargramostim in 2026
Figure 76. Manufacturing Process Analysis of Sargramostim
Figure 77. Industry Chain Structure of Sargramostim
Figure 78. Channels of Distribution
Figure 79. Global Sargramostim Sales Market Forecast by Region (2027-2032)
Figure 80. Global Sargramostim Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Sargramostim Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Sargramostim Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Sargramostim Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Sargramostim Revenue Market Share Forecast by Application (2027-2032)
